The U.S. Government is seeking information on mature host-based diagnostic technologies (preferably TRL 4 or higher) that use biomarkers to diagnose infections, predict clinical outcomes, and guide therapeutic treatments for warfighters exposed to CBRN threats. The ideal product should be small, battery-operable, and deliver results in under 70 minutes, with clinical sensitivity and specificity greater than 90%. Respondents must submit a white paper (max 3 pages) and a one-page Quad Chart detailing technical approach, regulatory status, manufacturing capabilities, and a Rough Order of Magnitude cost. No budget amount or performance location is specified in the description. This is a Request for Information only, with no solicitation currently available or guaranteed to be issued.